The Boston GlobeFDA approves X4 Pharmaceuticals' drug for ultra-rare WHIM syndromeApr 29jonathan saltzmanBy jonathan saltzmanmore_vert
ReutersUS FDA approves X4 Pharmaceuticals' therapy for immunodeficiency diseaseApr 29Christy SanthoshBy Christy Santhoshmore_vert
Investing.comEarnings call: X4 Pharmaceuticals reports Q1 2024 results and drug developmentsMay 7Natashya AngelicaBy Natashya Angelicamore_vert
Full CoverageFull Coverage
